Evidence map›Paper›PMID 33029235›Full record

ArticleActa endocrinologica (Bucharest, Romania : 2005)

THE ROLE OF NT PRO-BNP IN THE EVALUATION OF DIABETIC PATIENTS WITH HEART FAILURE.

F I Fringu, A V Sitar-Taut, B Caloian, D Zdrenghea, D Comsa, G Gusetu, D Pop

Abstract read
In one paragraph

Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

F I FringuUniversity of Medicine and Pharmacy, Clinical Rehabilitation Hospital, Cardiology Department, Cluj-Napoca, Romania.
A V Sitar-Taut"Babes-Bolyai" University, Cluj-Napoca, Romania.
B Caloian"Iuliu Haţieganu" University of Medicine and Pharmacy - Cardiology, Cluj-Napoca, Romania.
D ZdrengheaUniversity of Medicine and Pharmacy, Clinical Rehabilitation Hospital, Cardiology Department, Cluj-Napoca, Romania.
D Comsa"Iuliu Haţieganu" University of Medicine and Pharmacy - Cardiology, Cluj-Napoca, Romania.
G GusetuUniversity of Medicine and Pharmacy, Clinical Rehabilitation Hospital, Cardiology Department, Cluj-Napoca, Romania.
D PopUniversity of Medicine and Pharmacy, Clinical Rehabilitation Hospital, Cardiology Department, Cluj-Napoca, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe prevalence of patients with concomitant heart failure (HF) and diabetes mellitus (DM) is high.

objectiveTo analyze the role of NT-pro-BNP levels in the evaluation of diabetic patients with heart failure.

designRetrospective comparative cohort study. SUBJECTS AND

methodsA total of 174 patients admitted to our Cardiology Department, previously diagnosed with HF, were enrolled. Among these patients, 47.7% had DM. HF was defined according to the 2016 ESC criteria. The NT-pro BNP levels above 126 pg/mL indicate a high probability of heart failure.

resultsIn diabetic patients there were significant correlations between NT-pro-BNP values and the following parameters: hemoglobin (rho=-0.28, p=0.01), hematocrit (rho= -0.27, p=0.014), total cholesterol (rho= -0.21, p=0.048), triglycerides (rho= -0.283, p=0.01), ejection fraction (rho= -0.465, p<0.0001), end-diastolic volume (rho= 0.253, p= 0.026), end-systolic volume (rho= 0.29 p=0.01). Only the following 3 parameters: ejection fraction (p= 0.0009), hemoglobin (p= 0.0092) and triglycerides (p= 0.0380) were independent predictive factors for elevated NT-pro-BNP values.

conclusionIn diabetic heart failure patients, the value of NT-pro-BNP holds a pivotal role in the evaluation of their overall status, facilitating the establishment of correct management and follow-up.

Indexed as

diabetes mellitusheart failureNT-pro-BNP

Identifiers

PMID33029235
PMCPMC7535893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.